EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spinal Cord DNMT1 Contributes to Diabetic Neuropathic Pain Mediated by miR-152-3p Downregulation

Xiaobao Ding, Jingjing Li, Yuwen Lin, Wenli Hu, Mengyuan Zhou, Xinyu Li, Yuqing Wu, Chenghua Zhou

Neuropharmacology and Therapy · 2024

DOI: 10.15212/npt-2024-0008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropharmacology and Therapy, 2024. Verfasst von Xiaobao Ding und 7 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic neuropathic pain (DNP) is a common complication of diabetes, yet there are no safe and effective therapeutic options. Emerging evidence has indicated that DNA methylation mediated by DNA methyltransferases (DNMTs) is associated with neuropathic pain. However, how DNMTs respond to DNP and the underlying mechanism has not been established. In this study a DNP model was created and DNMT1, but not DNMT3a or DNMT3b, was shown to be upregulated in the spinal cords of mice with DNP. Moreover, DNMT1 was predominantly expressed in spinal cord neurons. Knockdown of DNMT1 in neurons improved nociceptive hypersensitivity in mice with DNP. Furthermore, bioinformatics analysis and real-time quantitative PCR results suggested that downregulated miR-152-3p in the spinal cord of mice with DNP may be an upstream DNMT1 molecule. Overexpression of miR-152-3p reduced DNMT1 expression in the spinal cord and alleviated nociceptive hypersensitivity in mice with DNP. Knockdown of miR-152-3p caused an increase in DNMT1 expression in the spinal cord and induced nociceptive hypersensitivity in naive mice. Moreover, knockdown of DNMT1 reversed miR-152-3p knockdown-induced nociceptive hypersensitivity in naive mice. These results suggest that downregulation of miR-152-3p in the spinal cord is involved in the development of DNP by upregulating DNMT1. These data demonstrate a new mechanism underlying the development of DNP and provide a new therapeutic target for DNP.

Zitieren

APA

Ding, X., Li, J., Lin, Y., Hu, W., Zhou, M., Li, X., Wu, Y., & Zhou, C. (2024). Spinal Cord DNMT1 Contributes to Diabetic Neuropathic Pain Mediated by miR-152-3p Downregulation. Neuropharmacology and Therapy. https://doi.org/10.15212/npt-2024-0008

Vancouver

Ding X, Li J, Lin Y, Hu W, Zhou M, Li X, et al. Spinal Cord DNMT1 Contributes to Diabetic Neuropathic Pain Mediated by miR-152-3p Downregulation. Neuropharmacology and Therapy. 2024. doi:10.15212/npt-2024-0008

BibTeX
@article{Ding2024,
  author = {Ding, Xiaobao and Li, Jingjing and Lin, Yuwen and Hu, Wenli and Zhou, Mengyuan and Li, Xinyu and Wu, Yuqing and Zhou, Chenghua},
  title = {Spinal Cord DNMT1 Contributes to Diabetic Neuropathic Pain Mediated by miR-152-3p Downregulation},
  journal = {Neuropharmacology and Therapy},
  year = {2024},
  doi = {10.15212/npt-2024-0008}
}
Kostenlos starten →